NPHLA Tracker · Clinical trials (ClinicalTrials.gov)
Clinical Trial Tracker: Metabolic & Aesthetic Medicine
Clinical trials followed in metabolic and aesthetic medicine — obesity and incretin therapies, neurotoxins, dermal fillers, regenerative treatments and hair restoration — with each study’s status, phase and latest registry update.
- Pending editorial review
A system check is an automated check of the official sources, not a human review. An editorial review is recorded only when one of our editors has reviewed the page.
- Records
- 300
- Changed in 7 days
- 7
- Latest record
- Jurisdiction
- International / multiple
Records
7 changed in the last 7 daysInvestigational therapies
Every therapy studied in a clinical trial is investigational and not approved for the use being studied. A trial’s phase and status describe the study, not whether the product works.
| Record | Status | Phase | Sponsor | Jurisdiction | Date | Source | Last checked |
|---|---|---|---|---|---|---|---|
| A Study of BGM0504 in Participants With Type 2 DiabetesNCT06716216Changed in the last 7 days Status changed from “Active, not recruiting” to “Completed” · Conditions: Type 2 Diabetes Mellitus (T2DM). Interventions: Drug: 5 mg BGM0504 Administered SC; Drug:10 mg BGM0504 Administered SC; Drug: Semaglutide Administered SC | Completed | Phase 3 | BrightGene Bio-Medical Technology Co., Ltd. | Not applicable | Last update posted | ClinicalTrials.gov (U.S. National Library of Medicine): ClinicalTrials.gov record NCT06716216 (opens in a new tab)Primary source | System checked NPHLA updated |
| Multimodal Liquid-Biopsy Omics Biomarkers of Treatment Response in Breast CancerNCT07880106Changed in the last 7 days Status changed from “Not yet recruiting” to “Recruiting” · Conditions: Lung Cancer Non-small Cell; Colorectal Cancer; Stomach Cancer; Hepatocellular Carcinoma; Breast Cancer | Recruiting | Phase not stated | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Not applicable | Last update posted | ClinicalTrials.gov (U.S. National Library of Medicine): ClinicalTrials.gov record NCT07880106 (opens in a new tab)Primary source | System checked NPHLA updated |
| TOPAZ: Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized TrialNCT07734792Changed in the last 7 days Status changed from “Not yet recruiting” to “Recruiting” · Conditions: Acute Ischemic Stroke (AIS). Interventions: Tirzepatide; Standard Medical Care (SMC) | Recruiting | Phase 2 / Phase 3 | yifang zhu | Not applicable | Last update posted | ClinicalTrials.gov (U.S. National Library of Medicine): ClinicalTrials.gov record NCT07734792 (opens in a new tab)Primary source | System checked NPHLA updated |
| A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 DiabetesNCT07112872Changed in the last 7 days Status changed from “Active, not recruiting” to “Recruiting” · Conditions: Type 2 Diabetes Mellitus. Interventions: Tifeglipron; Semaglutide; Placebo | Recruiting | Phase 2 | Hoffmann-La Roche | Not applicable | Last update posted | ClinicalTrials.gov (U.S. National Library of Medicine): ClinicalTrials.gov record NCT07112872 (opens in a new tab)Primary source | System checked NPHLA updated |
| BioM: Biological Profiles of Neuropeptides, Neurotrophins and miRNA in MigraineNCT07832032Changed in the last 7 days Status changed from “Not yet recruiting” to “Enrolling by invitation” · Conditions: Migraine. Interventions: Rimegepant 75 MG | Enrolling by invitation | Phase not stated | Nordlandssykehuset HF | Not applicable | Last update posted | ClinicalTrials.gov (U.S. National Library of Medicine): ClinicalTrials.gov record NCT07832032 (opens in a new tab)Primary source | System checked NPHLA updated |
| A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesNCT05936151Changed in the last 7 days Results first posted on ClinicalTrials.gov (2026-11-09) · Conditions: Overweight or Obesity; CKD; Type 2 Diabetes. Interventions: Retatrutide; Placebo | Completed | Phase 2 | Eli Lilly and Company | Not applicable | Last update posted | ClinicalTrials.gov (U.S. National Library of Medicine): ClinicalTrials.gov record NCT05936151 (opens in a new tab)Primary source | System checked NPHLA updated |
| Efficacy and Safety of Two Hair Supplements in Men With Androgenic AlopeciaNCT07806474Changed in the last 7 days Status changed from “Not yet recruiting” to “Recruiting” · Conditions: Androgenic Alopecia; Healthy Adult Male. Interventions: formulation of green tea leaf extract, bamboo shoot extract and selenium-enriched yeast; formulation of grape seed extr… | Recruiting | Not applicable | Activ'inside | Not applicable | Last update posted | ClinicalTrials.gov (U.S. National Library of Medicine): ClinicalTrials.gov record NCT07806474 (opens in a new tab)Primary source | System checked NPHLA updated |
How is this tracker compiled?
The Intelligence pipeline queries the ClinicalTrials.gov API (version 2) for two broad searches — obesity and incretin therapies, and aesthetic and regenerative medicine (botulinum toxin, dermal fillers, polynucleotides, exosomes, platelet-rich plasma) — and for every topic with a trial query, on the schedule set in the Source Registry. Each study is stored with its registry fields as published. Changes in overall status and newly posted results are recorded with the date the pipeline detected them.
This tracker lists every tracked study whose last registry update falls within the past 365 days, newest first. Nothing in the table is edited by hand.
Selection: ClinicalTrials.gov studies followed by Trial Watch dated within the last 365 days.
What does it cover?
Studies on ClinicalTrials.gov — from the United States and other countries — that match the configured searches, from the date tracking began. Studies registered elsewhere, described with other terms, or not updated in the last year are not included.
What are its limitations?
Registry data is supplied by sponsors and may be incomplete or out of date. Inclusion reflects search terms, not clinical importance. Every therapy in a trial is investigational for the use being studied. Not medical advice.
How often is it updated?
Registry searches run every 6 to 12 hours, as configured in the Source Registry.
System checked is the last time an automated check of the underlying official sources succeeded — it is not a human review. Editorially reviewed appears only when an editor has reviewed this tracker. Each row shows its own check: an automated system check or an editor’s verification.
Data origin: NPHLA analysis of public data. Professional reference only — not medical, legal or regulatory advice. Always confirm a record in its primary source. Spotted an error? Tell us.